These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 17664952
1. Combination therapy for rheumatoid arthritis: methotrexate and sulfasalazine together or with other DMARDs. Dale J, Alcorn N, Capell H, Madhok R. Nat Clin Pract Rheumatol; 2007 Aug; 3(8):450-8; quiz, following 478. PubMed ID: 17664952 [Abstract] [Full Text] [Related]
2. Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis. Hazlewood GS, Barnabe C, Tomlinson G, Marshall D, Devoe D, Bombardier C. BMJ; 2016 Apr 21; 353():i1777. PubMed ID: 27102806 [Abstract] [Full Text] [Related]
7. Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study. Capell HA, Madhok R, Porter DR, Munro RA, McInnes IB, Hunter JA, Steven M, Zoma A, Morrison E, Sambrook M, Wui Poon F, Hampson R, McDonald F, Tierney A, Henderson N, Ford I. Ann Rheum Dis; 2007 Feb 21; 66(2):235-41. PubMed ID: 16926184 [Abstract] [Full Text] [Related]
8. A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis. Jobanputra P, Wilson J, Douglas K, Burls A. Rheumatology (Oxford); 2004 Feb 21; 43(2):206-10. PubMed ID: 12923291 [Abstract] [Full Text] [Related]
9. Disease-modifying antirheumatic drugs. Potential effects in older patients. Gardner G, Furst DE. Drugs Aging; 1995 Dec 21; 7(6):420-37. PubMed ID: 8601050 [Abstract] [Full Text] [Related]
10. Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate. O'Dell JR, Haire C, Erikson N, Drymalski W, Palmer W, Maloley P, Klassen LW, Wees S, Moore GF. J Rheumatol Suppl; 1996 Mar 21; 44():72-4. PubMed ID: 8833058 [Abstract] [Full Text] [Related]
18. Triple Oral Therapy Versus Antitumor Necrosis Factor Plus Methotrexate (MTX) in Patients with Rheumatoid Arthritis and Inadequate Response to MTX: A Systematic Literature Review. Mary J, De Bandt M, Lukas C, Morel J, Combe B. J Rheumatol; 2017 Jun 21; 44(6):773-779. PubMed ID: 28412710 [Abstract] [Full Text] [Related]
20. Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial. Verschueren P, De Cock D, Corluy L, Joos R, Langenaken C, Taelman V, Raeman F, Ravelingien I, Vandevyvere K, Lenaerts J, Geens E, Geusens P, Vanhoof J, Durnez A, Remans J, Vander Cruyssen B, Van Essche E, Sileghem A, De Brabanter G, Joly J, Meyfroidt S, Van der Elst K, Westhovens R. Ann Rheum Dis; 2015 Jan 21; 74(1):27-34. PubMed ID: 25359382 [Abstract] [Full Text] [Related] Page: [Next] [New Search]